Medications

How an emerging drug class dampens harmful immune reactions

The complement system defends the body against microbial intruders, but it can also attack the body's own cells for various reasons and therefore contribute to clinical complications. These complications range from age-related ...

Health informatics

Study finds the risks of sharing health care data are low

In recent years, scientists have made great strides in their ability to develop artificial intelligence algorithms that can analyze patient data and come up with new ways to diagnose disease or predict which treatments work ...

Medical research

How a single protein could unlock age-related vision loss

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss. The study, published recently ...

Neuroscience

Developing a new human cell line to study blinding eye disorders

Under the direction of Boyd Professor Nicolas Bazan, MD, Ph.D., scientists at LSU Health New Orleans Neuroscience Center of Excellence have developed a new, experimental human cell line from retinal pigment epithelial cells. ...

Genetics

Streamlining stem cells to treat macular degeneration

As we age, so do our eyes; most commonly, this involves changes to our vision and new glasses, but there are more severe forms of age-related eye problems. One of these is age-related macular degeneration, which affects the ...

Genetics

A step closer to treatment for the most common form of blindness

Scientists at The University of Manchester have taken an important step towards finding a treatment for age-related macular degeneration (AMD), the most common form of adult blindness in the developed world. The researchers ...

Ophthalmology

Retinal stem cell patch sees progress

A retinal stem cell patch developed through a collaboration of researchers at UC Santa Barbara, University of Southern California and California Institute of Technology continues to make progress in its bid to secure approval ...

page 3 from 40